Skip to main content

Table 8 Comparison of adult formulation derived costs to the WHO Global Price Reporting Mechanism (GPRM) database

From: Estimating age-based antiretroviral therapy costs for HIV-infected children in resource-limited settings based on World Health Organization weight-based dosing recommendations

Medication (strength) Monthly costs for 35 + kg (from Table 3) Monthly costs from GPRM
ABC (300 mg) $15.81 $13.39
d4T (30 mg) $1.82 $1.52
3TC (150 mg) $2.43 $2.36
EFV (600 mg) $4.56 $3.86
LPV/r (200/50 mg) $31.62 $29.47
NVP (200 mg) $3.04 $2.47
ZDV (300 mg) $7.30 $6.98
ZDV/3TC (300 mg/150 mg) $9.12 $7.86
ZDV/3TC/NVP (300 mg/150 mg/200 mg) $11.55 $9.89
d4T/3TC (30 mg/150 mg) $3.65 $2.99
d4T/3TC/NVP (30 mg/150 mg/200 mg) $6.69 $4.76
ABC/3TC (600 mg/300 mg) $17.72-$32.53 $22.56
  1. Abbreviations: ABC abacavir, d4T stavudine, 3TC lamivudine, EFV efavirenz, LPV/r lopinavir/ritonavir, NVP nevirapine, ZDV zidovudine, mg milligrams, ml milliliter, NR not recommended, N/A not applicable (no cost estimate was available from the GPRM for this formulation).